It is also a plain fact that a solid economic case has been made to the UK's NHS economists about the economic and societal benefits. Given that these ulcers can be very painful, debilitating and also smell, and that the cost to the health budgets of Europe for treatment is far higher than using VitroGro there is no reason that can be advanced for not a) approving and b) offering partial or even total reimbursement.
It is a case of applying Occam's Razor. The simple explanation is to be preferred. Bureaucracies put their own interests first and make a virtue of delay as consideration and care, but in the end this is a simple, low cost effective treatment for an unmet need. The evidence is on the table. All the atmospherics are distracting attention from the obvious.
TIS Price at posting:
36.5¢ Sentiment: Buy Disclosure: Held
